June 12, 2026 a 08:00 am
JNJ: Fundamental Ratio Analysis - Johnson & Johnson
Johnson & Johnson represents a significant player in the healthcare sector. Following the divestment of its Consumer Health division, the company appears to be honed in on innovative medicine and MedTech. The restructuring moves are expected to enhance growth prospects and focus on core competences.
Fundamental Rating
Johnson & Johnson has received a solid "B+" rating in fundamentals, reflecting its strong positions in key financial metrics.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Review the progression of scores over time to gain insights into the company's financial dynamics.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
| N/A | 0 | 4 | 5 | 5 | 2 | 2 | 1 |
Analyst Price Targets
Based on analyst forecasts, Johnson & Johnson's price targets suggest potential upward movement.
| High | Low | Median | Consensus |
|---|---|---|---|
| 283 | 208 | 255 | Buy |
Analyst Sentiment
The sentiment among analysts is generally positive, with a strong inclination towards 'Buy'.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 21 | |
| Hold | 16 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Johnson & Johnson remains a formidable entity in the health care domain, retaining substantial investor confidence. The company's strategic refocus post-Kenvue separation is expected to accelerate growth, specifically in its MedTech and Innovative Medicine segments. Long-term prospects appear stable, though vigilance towards competition and regulatory hurdles is advised. Overall, the stock presents a balanced opportunity with moderate risks.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years